Wednesday, May 13, 2026
In Detail Full day, Wednesday, May 13, 2026, Timezone: America/Chicago
CMS pauses hospice, home health Medicare enrollments in fraud crackdown
fiercehealthcare - The Trump administration has issued a six-month moratorium on hospice and home health agencies enrolling in Medicare as part of its efforts to combat fraud.
AI Summary: CMS has suspended new Medicare enrollments for hospice and home health providers nationwide amid a fraud crackdown, pausing approvals while investigators audit suspicious applications and billing patterns. The freeze seeks to protect patients and taxpayer dollars, though it may delay access where new providers were expected to step in — because apparently some providers preferred creative billing over care.
- Nationwide moratorium on hospice and home health enrollments (4)
- Policy and patient access fallout from the freeze (3)
- White House fraud crackdown and enforcement sweep (4)
- All Other Stories
Nationwide moratorium on hospice and home health enrollments
Policy and patient access fallout from the freeze
White House fraud crackdown and enforcement sweep
All Other Stories
Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma
discovermagazine - Discover how a personalized DNA vaccine trained patients’ immune systems to target their own tumors, with one participant remaining cancer-free nearly five years later.
AI Summary: A customized vaccine targeting each patient's tumor has demonstrated encouraging immune responses and signs of clinical benefit against aggressive glioblastoma. Researchers report enhanced T‑cell activity and preliminary survival signals, suggesting personalized neoantigen vaccines may help control this stubborn brain cancer and warrant larger, controlled trials to confirm impact.
- New models and datasets speeding brain tumor research (3)
- Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells (3)
- Personalized glioblastoma vaccine: early immune and survival signals (3)
- All Other Stories
New models and datasets speeding brain tumor research
Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells
Personalized glioblastoma vaccine: early immune and survival signals
All Other Stories
Mayo Clinic CEO Gianrico Farrugia stepping down at year's end
fiercehealthcare - Mayo Clinic is looking for a new leader as Gianrico Farrugia, M.D., who has served as president and CEO since 2019, announced he would step down at the end of this year.
AI Summary: Gianrico Farrugia will step down as Mayo Clinic CEO at the end of the year, closing a chapter at one of the nation’s flagship health systems. The move triggers leadership succession planning and board attention amid continuing strategic and operational challenges, as the institution prepares for new stewardship while reassuring staff and patients.
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Eli Lilly, Medicare Advantage (not listed), Autism, Venture Capital and look for the RSS link.
StackHealth Time Machine
More StackHealth